Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.38 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.37 |
| ▸ | RIOK2 | Q9BVS4 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29874031 | 1.00 | CYP2A6 (0.50) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL29853165 | 1.00 | CYP2A6 (0.50) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL21808752 | 0.89 | HPRT1 (0.58) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL29614596 | 0.89 | HPRT1 (0.58) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL29616881 | 0.89 | HPRT1 (0.58) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL1705748 | 0.89 | HPRT1 (0.58) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL31252822 | 0.89 | HPRT1 (0.58) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Dibenzothiophene SCHEMBL29047506 | 0.88 | GPR3 (0.52) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL18740350 | 0.85 | HSD17B10 (0.44) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL28841274 | 0.84 | HSD17B10 (0.43) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114335353-A | Solar spectrum wavelength conversion material and solar cell comprising same | 韩华道达尔有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114097096-A | Solar energy conversion material, solar cell package including the same, and solar cell including the same | 韩华道达尔有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-106715422-A | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | 忠南大学校产学协力团 | 2017-05-24 | — | — | CN | claimed |
| US-12558341-B2 | Oral complement factor D inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250186391-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2025-06-12 | — | — | US | disclosed |
| CN-119841856-A | Light-emitting device, electronic apparatus, electronic device, and heterocyclic compound | 三星显示有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-20250092067-A1 | APT1 and APT2 Inhibitors and Uses Thereof | CORNELL UNIVERSITY | 2025-03-20 | — | — | US | disclosed |
| CN-119638751-A | Light-emitting device including organometallic compound, electronic apparatus and electronic device including light-emitting device, and organometallic compound | 三星显示有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119522000-A | Method for manufacturing light-emitting device, light-emitting device manufactured thereby, and electronic apparatus | 三星显示有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119486550-A | Composition, light-emitting device using the same, and electronic apparatus and electronic device including the light-emitting device | 三星显示有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119451531-A | Light-emitting device including organometallic compound, electronic apparatus and electronic device including the same, and organometallic compound | 三星显示有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-6096144-A | TREATING WITH ACIDIC OR ALKALINE SOLUTION OF CONJUGATED UNSATURATED COMPOUND WITH AT LEAST 5 BONDS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-08-01 | — | — | US | disclosed |
| EP-0872903-A1 | Method for making hydrogen storage alloy powder and electrode comprising the alloy powder | Shin-Etsu Chemical Co., Ltd. (JP) | 1998-10-21 | — | — | EP | disclosed |
| CN-1006386-B | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | SHINETSU CHEM IND CO (JP) | 1990-01-10 | — | — | CN | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| CN-85107531-A | Process for producing vinyl chloride polymer | — | 1987-01-21 | — | — | CN | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4171366-A | 1-Naphthothienylalkyl-1H-imidazoles | CIBA-GEIGY CORPORATION (US) | 1979-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092067-A1 | APT1 and APT2 Inhibitors and Uses Thereof | LYPLA2, LYPLA1, PPT1 | CYP2A6 3708/4885ALDH1A1 3083/4885HSD17B10 750/4885 |
| US-12558341-B2 | Oral complement factor D inhibitors | CFD, CFH, CFB | CYP2A6 1256/4885ALDH1A1 2667/4885HSD17B10 1149/4885 |
| US-20250186391-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | CFD, CFH, CFB | CYP2A6 1436/4885ALDH1A1 3142/4885HSD17B10 2891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.